Katakura Industries (3001) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
20 Mar, 2026Executive summary
Operating income rose to ¥4,124M, up 8.4% or ¥321M year-over-year, despite a 1.4% or ¥548M decline in net sales to ¥39,424M, mainly due to declines in pharmaceuticals and textiles, offset by real estate and machinery growth.
Profit attributable to owners of parent increased by 15.7% or ¥479M to ¥3,524M year-over-year, aided by gains from investment securities sales and special retirement payments.
Extraordinary income surged due to proceeds from sales of investment securities, while extraordinary losses decreased mainly from lower impairment losses.
Financial highlights
Net sales: ¥39,424M (down ¥548M YoY); Operating income: ¥4,124M (up ¥321M YoY); Operating margin: 10.5% (up 1.0pt YoY).
Ordinary income: ¥5,483M (up ¥415M YoY); Profit attributable to owners: ¥3,524M (up ¥479M YoY).
Extraordinary income: ¥2,930M (up ¥2,126M YoY); Extraordinary loss: ¥1,016M (down ¥293M YoY).
Comprehensive income was ¥4,426M, down 6.9% YoY.
Dividend per share for the year was ¥50, with a payout ratio of 46.4%.
Outlook and guidance
FY2025 forecast: Net sales ¥40,600M (up ¥1,176M or 3.0% YoY), operating income ¥4,600M (up ¥476M or 11.5% YoY), operating margin 11.3%.
Profit attributable to owners forecasted at ¥4,000M (up ¥476M or 13.5% YoY).
The company plans to maintain a ¥50 dividend per share for FY2025.
Focus remains on structural reforms, real estate as a core business, and investment in functional fibers and IT.
Real Estate sales and earnings expected to rise, though earnings will be offset by higher property taxes and facility renewal costs.
Latest events from Katakura Industries
- Revenue fell 4.7% YoY, with stable operating profit and ongoing pharma restructuring.3001
Q2 202420 Mar 2026 - Revenue and profit fell on machinery and textile weakness, but real estate grew; dividend raised.3001
Q3 202420 Mar 2026 - Q1 revenue and profit rose sharply, driven by machinery, with stable outlook and share buyback planned.3001
Q1 202520 Mar 2026 - Net income nearly doubled on strong machinery sales and asset gains; full-year outlook raised.3001
Q2 202520 Mar 2026 - Net income surged 90.4% year-over-year, driven by machinery gains and asset sales.3001
Q3 202520 Mar 2026 - Strong profit growth driven by machinery and real estate; cautious FY2026 outlook.3001
Q4 202520 Mar 2026